![Catherine Marle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Catherine Marle held the position of Head-Clinical Operations at AB Science SA from 2015 to 2019 and later served as Chief Operating Officer at Enterome SA from 2019 to 2022.
Antiguos cargos conocidos de Catherine Marle.
| Empresas | Cargo | Fin |
|---|---|---|
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Director de Operaciones | 01/07/2022 |
| AB SCIENCE | Director Técnico/Científico/I+D | 01/01/2019 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
4
Relaciones de 1er grado
2
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
AB Science SA
 AB Science SA Pharmaceuticals: OtherHealth Technology Provides biochemical research services | Health Technology |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Health Technology |
- Bolsa de valores
- Insiders
- Catherine Marle
Elige MarketScreener 
